The Growing Demand for Medical Weight Management Services Adult obesity prevalence was 41.9% in 20172020 (CDC/NCHS), creating significant health and economic burdens 1
doi: 10.5603/EP.a2020.0049 53
The medications approval by the US Food and Drug Administration (FDA) underscores its efficacy and safety in addressing weight-related concerns for adults with obesity or overweight and obese adolescents aged 12 and older
More people than ever are talking about GLP-1 medications and more are quietly wondering what happens when you stop taking them
Yin Yang 1 (YY1), a highly conserved C2H2 zinc finger nuclear transcription factor that is overexpressed in M2 macrophages within PCa tissues, plays a crucial role in this process (Cho et al., 2018)
Back Molteni, M (17 Oct 2023) 'How one scientist's determination made Novo Nordisk an obesity-drug powerhouse', STAT News